Skip to Content
  • 2.2
    Impact Factor
  • 23 days
    Submission to First Decision
  • 4 days
    Acceptance to Publication

Pharmacy

Pharmacy is an international, scientific, peer-reviewed, and open access journal dealing with pharmacy education and practice, and is published monthly online by MDPI. The Academy of Pharmaceutical Sciences (APS) is affiliated with Pharmacy and its members receive discounts on the article processing charges.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (1,843)

  • Review
  • Open Access

Background: Patients with non-small-cell lung cancer (NSCLC) increasingly receive oral targeted therapies and immune checkpoint inhibitors, creating complex medication-management and toxicity-monitoring needs. Pharmacists may contribute through medication optimization, adherence support, patient education, drug-interaction management and multidisciplinary toxicity prevention. Objectives: The objectives of this study were To systematically map the published evidence describing pharmacist and pharmaceutical-care roles relevant to medication safety, adherence, toxicity management, and treatment continuity in NSCLC. Methods: A scoping review was conducted using PubMed/MEDLINE and Web of Science, supplemented by citation and supplementary searching. The search was limited to English-language publications published between 28 August 2016 and 28 August 2026. After reconciliation, 481 unique records were screened. Eligibility was assessed against a NSCLC-specific population and pharmacy/pharmaceutical-care concept criteria. Evidence was classified as core/direct or contextual/supporting. The selection process was reported according to PRISMA-ScR. Results: Of 481 unique records screened, 444 were excluded at title/abstract screening and 37 reports underwent an eligibility assessment. Twenty-three were excluded at this stage, leaving 14 sources of evidence: 11 core/direct and three contextual/supporting sources. Core evidence covered medication optimization and drug–drug interactions, adherence monitoring, adverse-event/toxicity management, patient education, and pharmacist-led ambulatory or multidisciplinary services. Conclusions: Pharmacists contribute meaningfully to medication safety, adherence, toxicity management, and treatment continuity in NSCLC, but the evidence base remains heterogeneous. Larger prospective studies and economic evaluations are needed.

Pharmacy

19 November 2026

PRISMA-ScR flow diagram based on the final reconciled eligibility audit.
  • Review
  • Open Access

Pharmaceutical indication and pharmacist prescribing are distinct mechanisms through which community pharmacists can contribute to primary care, particularly in managing minor symptoms and low-complexity conditions. This narrative review critically compared scientific, regulatory, and institutional sources identified through PubMed/MEDLINE, ScienceDirect, Google Scholar, and consultation of regulatory and professional documents. Domains of the Scale for the Assessment of Narrative Review Articles (SANRA) informed appraisal of the manuscript, rather than source selection or assessment of individual studies. Four recurrent analytical configurations were identified: pharmaceutical indication, protocol-based medicine supply or prescribing, collaborative prescribing, and independent prescribing. Their legal bases, clinical scopes, medicine-access mechanisms, and implementation requirements differ between and within jurisdictions. In the examples reviewed, structured services variously specify eligibility criteria, red-flag assessment, safety-netting, referral, documentation, and coordination with other healthcare professionals. Heterogeneous study designs and outcome measures limit comparisons of clinical effectiveness, safety, service utilization, and costs; no universal hierarchy among regulatory configurations can be established. In selected Latin American settings, including Costa Rica, pharmaceutical consultation and indication are documented, although formalization varies. Future research should prioritize comparable definitions, standardized outcomes, and sustainability.

Pharmacy

17 November 2026

Selected geographical examples of pharmaceutical indication, protocol-based supply, and pharmacist prescribing. Country highlighting is illustrative; regulatory authority may be subnational. England depicts the original PGD-based Pharmacy First pathways; the October 2026 prescribing extension is discussed in Section 3.3 and Table 1 and Table 2. Source: prepared by the authors based on references [4,8,10,11,14,15,16,20,21,22,23,24].
  • Article
  • Open Access

Bulgaria lacks routine EQ-5D-5L data collection and a national value set, so domestic health technology assessment relies on imported utility values. This study evaluated whether existing evidence justifies a feasibility study of routine EQ-5D-5L measurement in community pharmacies. In this cross-sectional study, reported according to STROBE, we analysed secondary data from a previously published pharmacy-based patient survey and primary data from a new pharmacist survey on questionnaire-based mental health screening, and used both to specify its design. In the source study (n = 119), complete EQ-5D-5L data were obtained from all enrolled participants (mean utility 0.72, 95% CI 0.679–0.756), with directionally consistent known-groups differences; the number of patients approached, administration time and acceptability were not reported. Among surveyed pharmacists (n = 105; convenience sample, response rate not calculable), 80.0% would undertake training and 75.2% would participate in a screening service given clear referral procedures; leading constraints were lack of confidential space (79.0%), time (64.8%) and trained staff (56.2%). Familiarity with PHQ-9/GAD-7 was associated with greater willingness (risk difference 20.5 percentage points, 95% CI 3.9–35.9). EQ-5D-5L-specific readiness was not assessed. Because key feasibility parameters are unknown, a prospective multicentre feasibility study is justified; its endpoints and provisional progression criteria are specified.

Pharmacy

12 November 2026

Hypothesised service logic for measurement-enabled personalized pharmacy care. Routine EQ-5D-5L measurement during the pharmacy visit could generate an individual HRQoL profile serving two potential purposes: at the individual level, informing pharmacist action as part of personalized pharmacy care; at the system level, contributing aggregated, de-identified real-world evidence for health technology assessment and service evaluation. Both pathways are hypotheses to be tested. Longitudinal collection, a design element of the proposed feasibility study, would additionally be required for QALY-based evaluation.
  • Article
  • Open Access

Background: Medication review (MR) requires pharmacists to identify medication-related problems (MRPs)/drug-related problems (DRPs), assess their clinical significance, and implement appropriate interventions. However, structured MR training for community pharmacists in Japan remains limited. Objective: To describe Japanese community pharmacists’ self-assessed competencies in MR immediately after participating in a structured workshop based on the Australian ASK–ASSESS–ADVISE framework. Methods: A post-workshop cross-sectional survey was conducted among community pharmacists who attended a one-and-a-half-day MR workshop at four locations in Japan. Participants completed a 31-item self-assessment questionnaire covering four domains (knowledge of MRPs/DRPs and ASK, ASSESS, and ADVISE processes), using a five-point Likert-type scale. Descriptive statistics were used to summarize responses, and internal consistency was assessed using Cronbach’s alpha. Results: A total of 124 pharmacists participated in the survey (response rate: 91.9%). Self-assessed competencies varied across the four domains and individual items. Descriptively, the proportions of participants who rated themselves as confident in performing the tasks (responses of four or five) were lower in Domain 3 (ASSESS process) than in the other domains, particularly for Items 6–10, for which the proportions ranged from 53.2% to 58.9%. These items involved prioritizing MRPs/DRPs, justifying intervention decisions, developing and evaluating intervention plans, and developing monitoring plans. Conclusion: This study describes community pharmacists’ self-assessed MR competencies immediately after a structured workshop. The findings indicate variation in perceived competencies across MR tasks, with particular attention warranted for clinical assessment, intervention planning, and monitoring within the ASSESS process. These findings may help identify priorities for future MR education and objective competency assessment among Japanese community pharmacists.

Pharmacy

11 November 2026

Self-reported assessment of Domain 1 to assess competency in knowledge and skills related to the identification and assessment of MRPs/DRPs. (Cronbach’s Alpha: 0.769).

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
Pharmacy - ISSN 2226-4787